Acadia Pharmaceuticals, Inc.
Biopharmaceutical company reports first quarter loss of $5.6M
Published in Pharma Investments, Ventures and Law Weekly, June 12th, 2005
Acadia reported a net loss of $5.6 million for the first quarter of 2005, compared to a net loss of $6.5 million for the first quarter of 2004.
At March 31, 2005, Acadia's cash, cash equivalents and investment securities totaled $41.6 million compared to $35.9 million at December 31, 2004. The increase in cash was primarily due to Sepracor, Inc.'s purchase of shares of Acadia's common stock for $10 million at a 40% premium to a 30-day trailing average closing price, in connection with a new collaboration agreement, partially...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- A.P. Pharma, Inc.
Pharmaceutical firm reports loss of $0.05 per share, clinical trial update - AC Immune
Swiss biotech company raises CHF 21M in private financing - Abbott
Sales increase 14% for pharmaceutical company - Access Pharmaceuticals, Inc.
Pharmaceutical firm records loss of $0.16 per share - Advancis Pharmaceutical Corporation
Private placement of common equity closed by pharma firm - Aeolus Pharmaceuticals, Inc.
Pharmaceutical company records loss of $0.12 per share, reports on ALS drug - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
